MedPath

EXONEURAL NETWORK AB

🇸🇪Sweden
Ownership
Holding
Employees
-
Market Cap
-
Website
http://www.exopulse.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

The Exopulse Mollii Suit Study - a Database for Routine Follow-up of Clinical Outcomes

Not yet recruiting
Conditions
Neurologic Disorder
Spinal Cord Injuries
Cerebral Palsy
Multiple Sclerosis
Stroke
First Posted Date
2023-06-13
Last Posted Date
2023-09-13
Lead Sponsor
Exoneural Network AB
Target Recruit Count
200
Registration Number
NCT05901259
Locations
🇸🇪

Exoneural Network Ab, Bergshamra, Stockholm, Sweden

Exopulse Mollii Suit, Motor Functions & CP Children With Cerebral Palsy

Not Applicable
Recruiting
Conditions
Spasticity
Muscle
Diplegia
Tetraplegia
Balance
Hemiplegia
Cerebral Palsy
Pain Syndrome
First Posted Date
2023-06-01
Last Posted Date
2024-01-30
Lead Sponsor
Exoneural Network AB
Target Recruit Count
34
Registration Number
NCT05885139
Locations
🇩🇪

Pohlig GmbH, Traunstein, Bavaria, Germany

🇩🇪

Medizinische Hochschule Hannover (MHH), Hanover, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.